New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2

Biochemical and Biophysical Research Communications

Volumn 382, Issue 1, 2009, Pages 26-29

  Ragona, Laura ^a   Tomaselli, Simona ^a   Quemener, Cathy ^b,c   Zetta, Lucia ^a   Bikfalvi, Andreas ^b,c  

^a CNR   (Italy)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Angiogenesis; CXCL4; Fibroblast growth factor 2; Interaction studies; NMR; Saturation transfer experiments

Indexed keywords

CHEMOKINE; CXCL4 CHEMOKINE; FIBROBLAST GROWTH FACTOR 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; HYDROPHOBICITY; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 63149141296     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.092     Document Type: Article

References (19)

1. Lasagni L., Grepin R., Mazzinghi B., Lazzeri E., Meini C., Sagrinati C., Liotta F., Frosali F., Ronconi E., Alain-Courtois N., Ballerini L., Netti G.S., Maggi E., Annunziato F., Serio M., Romagnani S., Bikfalvi A., and Romagnani P. PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion. Blood 109 (2007) 4127-4134
2. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., Carson H.F., and Sharpe R.J. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247 (1990) 77-79
3. Perollet C., Han Z.C., Savona C., Caen J.P., and Bikfalvi A. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 91 (1998) 3289-3299
4. Jouan V., Canron X., Alemany M., Caen J.P., Quentin G., Plouet J., and Bikfalvi A. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood 94 (1999) 984-993
5. Hagedorn M., Zilberberg L., Lozano R.M., Cuevas P., Canron X., Redondo-Horcajo M., Gimenez-Gallego G., and Bikfalvi A. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. FASEB J. 15 (2001) 550-552
6. Sharpe R.J., Byers H.R., Scott C.F., Bauer S.I., and Maione T.E. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J. Natl. Cancer Inst. 82 (1990) 848-853
7. Tanaka T., Manome Y., Wen P., Kufe D.W., and Fine H.A. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat. Med. 3 (1997) 437-442
8. Maione T.E., Gray G.S., Hunt A.J., and Sharpe R.J. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51 (1991) 2077-2083
9. Kolber D.L., Knisely T.L., and Maione T.E. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J. Natl. Cancer Inst. 87 (1995) 304-309
10. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., Sagrinati C., Mazzinghi B., Orlando C., Maggi E., Marra F., Romagnani S., Serio M., and Romagnani P. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197 (2003) 1537-1549
11. Romagnani P., Maggi L., Mazzinghi B., Cosmi L., Lasagni L., Liotta F., Lazzeri E., Angeli R., Rotondi M., Fili L., Parronchi P., Serio M., Maggi E., Romagnani S., and Annunziato F. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J. Allergy Clin. Immunol. 116 (2005) 1372-1379
12. Lozano R.M., Redondo-Horcajo M., Jimenez M.A., Zilberberg L., Cuevas P., Bikfalvi A., Rico M., and Gimenez-Gallego G. Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity. J. Biol. Chem. 276 (2001) 35723-35734
13. Van den Berghe L., Mortier I., Zanibellato C., Amalric F., Prats H., and Bugler B. FGF-2 dimerization involvement in growth factor mediated cell proliferation but not cell differentiation. Biochem. Biophys. Res. Commun. 252 (1998) 420-427
14. Bax D.G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65 (1985) 355-360
15. Hwang T.L., and Shaka A.J. Multiple-pulse mixing sequences that selectively enhance chemical exchange or cross-relaxation peaks in high-resolution NMR spectra. J. Magn. Reson. 135 (1998) 280-287
16. Mayer M., and Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123 (2001) 6108-6117
17. Joukov V., Kumar V., Sorsa T., Arighi E., Weich H., Saksela O., and Alitalo K. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J. Biol. Chem. 273 (1998) 6599-6602
18. Mohammadi M., Olsen S.K., and Ibrahimi O.A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16 (2005) 107-137
19. Plotnikov A.N., Hubbard S.R., Schlessinger J., and Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101 (2000) 413-424